key: cord-0976292-arupvxvg authors: Ondracek, Anna S.; Lang, Irene M. title: Neutrophil Extracellular Traps as Prognostic Markers in COVID-19: A Welcome Piece to the Puzzle date: 2021-01-28 journal: Arterioscler Thromb Vasc Biol DOI: 10.1161/atvbaha.120.315633 sha: 22db7d35060f1132e48dfb41bf6a07226e2c3a71 doc_id: 976292 cord_uid: arupvxvg nan T he article by Ng et al 1 is highlighting the presence of circulating neutrophil extracellular traps (NETs) in coronavirus disease 2019 and their role as prognostic indicator. The initial description of NETs in plasma of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients in April 2020 2 has focused interest in neutrophil function and NET formation in this condition. Severe COVID-19 cases are putting pressure on health care systems and particularly on intensive care units with median lengths of intensive care unit stay ranging from 6 to 12 days in studies conducted in China and 4 to 19 days in studies outside of China. 3 But which features make NETs determinants of clinical outcome and do we actually have sufficient data to support a specific role in COVID-19? The concept of NETosis was introduced in 2004 4 as release of extracellular DNA traps by neutrophils, composed of decondensed chromatin and granule proteins. NETosis-inducing agents (Figure) are bacteria, fungi, protozoa, viruses, platelets, cytokines, and nitric oxide donors. NET formation is a form of cell death 47 involving the translocation of elastase and myeloperoxidase from primary granules to the nucleus where they cleave histones after hypercitrullination catalyzed by PAD-4 (peptidylarginine deiminase 4), leading to chromatin decondensation. 48 Although NET generation has been described initially as an antimicrobial mechanism, recent data suggest that NETs contribute to lung injury, 30, 49 vascular thrombosis, 50 and multiple other conditions ( Figure) . Circulating surrogate markers of NETs in plasma are complexes of DNA and myeloperoxidase, 2, 9, 17, [51] [52] [53] citrullinated histone H3, 2,51,53 cell-free DNA, 2,51,53 and neutrophil elastase. 51 The data of Ng 1 are based on a relatively large patient number including 5-month follow-up samples compared with previous studies. However, for the assessment of outcomes, robust statistical methodology will be needed, with multivariate analyses of large sample sets corrected for confounders, such as age and cardiovascular risk factors. Drastic changes in blood neutrophils can originate from mobilization of neutrophils from the marginated pool of the lung via CXCR4 (C-X-C motif chemokine receptor 4)-CXCL12 (C-X-C motif chemokine ligand 12) interactions leading to a spill-over of the pulmonary inflammatory process to the systemic circulation. 54 Authors' observation that circulating NETs markers correlate with markers of inflammation and endothelial damage in COVID-19 1 emphasize the relevance of the virus for the vasculature, and centers the causes for patients' demise on the microvascular thrombosis aspect of the infection. 50 Although SARS-CoV-2-derived mRNA may not be detectable in blood during active infection, 55 the virus is able to directly infect activated neutrophils via surface ACE-2 (angiotensin-converting enzyme 2). 17 Authors demonstrate derangement of the endothelial activation/ damage marker VWF (von Willebrand factor) and its protease, ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin motifs 13), 1 which is an elegant suggestion of endothelial injury and potential microthrombosis that is in proportion with markers of NETs. Mechanisms on how virus/various-length-pieces of circulating DNA exert ADAMTS-13 suppression are unknown. The lung retains primed neutrophils, a protective mechanism shown to be impaired in acute respiratory distress syndrome. 56 NETs released by SARS-CoV-2-activated neutrophils promote lung epithelial cell death in vitro 17 and neutrophil infiltration. Interstitial NETs and intravascular thrombi are characteristic features of acute respiratory distress syndrome lungs in lethal COVID-19 cases. 17,57-59 NETs were found in airways together with fibrin occluding alveoli and bronchioles. 57 NETs trigger coagulation 60 and foster fibrin deposition in the airways compromising pulmonary ventilation and gas diffusion capacity. In accordance, Ng et al 1 show that higher circulating NETs levels are associated with the need for respiratory support and with mortality, which confirms smaller studies. 9 By contrast, other reports indicated that ventilator-dependent patients exhibited higher concentrations of cell-free DNA 2,51 which signifies general cell death and is not specific for neutrophils. Establishing causality between NETs burden and poor outcome highlights an urgent need for representative models of SARS-CoV-2 infection. So far, ferrets and hamsters are reported to come closest to humans, considering virus replication, clinical signs, pneumonia, transmission, immunology, and demographics. 61 However, all available models to date seem to lack formation of NETs and lung thrombosis, 62 suggesting that they do not serve to study severe SARS-CoV-2 infection. Circulating deoxyribonucleases (DNase) may be another important puzzle piece in COVID-19. Deoxyribonucleases 1 and 1L3 are naturally regulating the amount of circulating extracellular chromatin, and intact endogenous plasma DNase activity is essential for homeostasis and survival. 63 No data on DNase activity in patients have been published, leaving us puzzled about its association with disease severity and potential effects on circulating NETs markers. For the full picture, authors should analyze DNase activity in their samples. Directly targeting NETs by deoxyribonucleases has been proposed as a therapeutic approach in COVID-19, even before the first data on circulating NETs markers had been published. 59 Eight trials are currently registered on ClinicalTrials.gov to test the effect of NETs degradation, whereby 6 are recruiting patients with respiratory failure/acute respiratory distress syndrome. Design and outcome of these studies will likely impact our view on the role of NETs in SARS-CoV-2 pathophysiology. There are still many hurdles to take. What if there exists a significant component of immune-mediated, virusindependent immunopathology as a primary mechanism in severe disease, do NETs still play a role? Immunosenescence of neutrophils is only partially understood, but inaccurate chemotaxis and reduced pathogen clearance are expected to result in increased tissue damage. 64 These observations could affect treatment success and effectiveness and might require prospective stratification of analyses. In addition, dynamics of degradation and formation of cleavage products are likely to differ between compounds and routes of administration. Inflammatory responses of monocytes to chromatin depend on fragmentation into mononucleosomes and dinucleosomes, which are histones still wrapped in DNA. 31 The complexity of synergistic signaling by citrullinated nucleosomes goes beyond the cytotoxicity of circulating naked histones. 31 Authors' observation that elevated circulating NETs markers are prognostic indicators for outcomes in patients with COVID-19 1 is a simple and welcome puzzle piece in a tricky setting. Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria. Dr Lang has relationships with drug companies, including AOPOrphan Pharmaceuticals AG, Actelion-Janssen, MSD, United Therapeutics, Medtronic, and Ferrer. In addition to being investigator in trials involving these companies, relationships include consultancy service, research grants, and membership of scientific advisory boards. The other author reports no conflicts. Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19 Neutrophil extracellular traps in covid-19 COVID-19 length of hospital stay: a systematic review and data synthesis Neutrophil extracellular traps kill bacteria. Science An emerging role for neutrophil extracellular traps in noninfectious disease Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights Extracellular DNA traps promote thrombosis The state of art of neutrophil extracellular traps in protozoan and helminthic infections Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome Neutrophil extracellular traps are elevated in patients with pneumonia-related acute respiratory distress syndrome Circulating neutrophil and eosinophil extracellular traps are markers of severe asthma Neutrophil extracellular traps go viral Neutrophil extracellular traps in fungal infection Extracellular DNA NETworks with dire consequences for health Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones SARS-CoV-2-triggered neutrophil extracellular traps mediate covid-19 pathology Citrullination of autoantigens implicates NETosis in the induction of autoimmunity Understanding the entanglement: Neutrophil Extracellular Traps (NETs) in cystic fibrosis The role for neutrophil extracellular traps in cystic fibrosis autoimmunity Neutrophil extracellular traps promote deep vein thrombosis in mice Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality Peptidylarginine deiminase 4 promotes age-related organ fibrosis Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction Oxidized LDL induced extracellular trap formation in human neutrophils via TLR-PKC-IRAK-MAPK and NADPH-oxidase activation Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury DNA, and citrullination promote neutrophil extracellular trap inflammation by regulating the localization and activation of TLR4 Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size Neutrophil extracellular traps in immunity and disease Neutrophil extracellular traps in ischemic stroke thrombi Novel contributions of neutrophils in the pathogenesis of abdominal aortic aneurysm, the role of neutrophil extracellular traps: A systematic review Degradation of extracellular DNA by DNase1 significantly reduces testicular damage after testicular torsion in rats NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease Neutrophil extracellular traps drive inflammatory pathogenesis in malaria The emerging role of Neutrophil Extracellular Traps (NETs) in tumor progression and metastasis DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25 Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis Neutrophil extracellular traps regulate IL-1β-mediated inflammation in familial Mediterranean fever Skin and systemic inflammation in Schnitzler's syndrome are associated with neutrophil extracellular trap formation REDD1/Autophagy pathway is associated with neutrophil-driven IL-1β inflammatory response in active ulcerative colitis Novel cell death program leads to neutrophil extracellular traps Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses Vascular occlusion by neutrophil extracellular traps in COVID-19 Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis Neutrophil extracellular traps and thrombosis in covid-19 Neutrophil mobilization via plerixaformediated CXCR4 inhibition arises from lung demargination and blockade of neutrophil homing to the bone marrow Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe covid-19 Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19 Targeting potential drivers of covid-19: neutrophil extracellular traps Thrombosis as an intravascular effector of innate immunity Animal models for COVID-19 Animal models of mechanisms of SARS-CoV-2 infection and COVID-19 pathology Host DNases prevent vascular occlusion by neutrophil extracellular traps Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence